Abstract:Our previous study revealed that Type II cGMP-dependent protein kinase (PKG II) inhibits epidermal growth factor (EGF)-induced MAPK/ERK and MAPK/JNK-mediated signal transduction through the inhibition of the phosphorylation/activation of the EGF receptor (EGFR). As EGFR also mediates several other signal transduction pathways besides MAPK-mediated pathways, the present study was designed to investigate whether PKG II was able to inhibit EGF/EGFR-induced phosphatidylinositol-3-kinase (PI3K)/Akt-mediated signal transduction. The AGS human gastric cancer cell line was infected with adenoviral constructs encoding a cDNA of PKG II (Ad-PKG II) to increase the expression of PKG II, and treated with 8-pCPT-cGMP to activate the enzyme. Western blotting was used to detect the phosphorylation/activation of the key components of the signal transduction pathway, including EGFR, PI3K, Akt, mTOR and NF-κB. The levels of apoptosis-related proteins, including Bax, Bcl-2, caspase 9 and DNA fragment factor (DFF), were also determined by western blotting. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining was used to detect the apoptosis of the AGS cells. The results revealed that EGF treatment increased the phosphorylation (activation) of EGFR, PI3K, Akt and mTOR, and increased the nuclear localization (activation) of NF-κB. EGF treatment also reduced the apoptosis of the AGS cells and increased the expression of the anti-apoptotic protein, Bcl-2, but had no effect on the expression of the pro-apoptotic protein, Bax, and did not alter the levels of caspase 9 and DFF. Increasing the PKG II activity of AGS cells by infecting them with Ad-PKG II and stimulating them with 8-pCPT-cGMP inhibited the EGF-induced activation of EGFR, PI3K, Akt, mTOR and NF-κB; caused an increase in caspase 9 breakdown (activation) and DFF levels; and reversed the anti-apoptotic effect of EGF. The results suggest that PKG II may also inhibit EGF-induced signal transduction of PI3K/Akt-mediated pathways, and further confirm that PKG II is able to block the activation of EGFR.

Active PKG II Inhibited the Growth and Migration of Ovarian Cancer Cells Through Blocking Raf/MEK and PI3K/Akt Signaling Pathways

PKG II Inhibits EGF/EGFR-induced Migration of Gastric Cancer Cells.

Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway

Expression of PKG2 in Ovarian Cancer and Its Effect on Epidermal Growth Factor Receptor.

Type Ii Cgmp-Dependent Protein Kinase Inhibits the Migration, Invasion and Proliferation of Several Types of Human Cancer Cells

The constitutively active PKG II mutant effectively inhibits gastric cancer development a blockade of EGF/EGFR-associated signalling cascades.

Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.

PKG II Effectively Reversed EGF-induced Protein Expression Alterations in Human Gastric Cancer Cell Lines.

Platelet-activating Factor Acetyl Hydrolase IB2 Dysregulated Cell Proliferation in Ovarian Cancer

Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?

Type Ii Cgmp-Dependent Protein Kinase Inhibits Activation Of Key Members Of The Rtk Family In Gastric Cancer Cells

cGMP-dependent protein kinase (PKG II) inhibits epidermal growth factor (EGF)-induced MAPK/ERK and MAPK/JNK-mediated signal transduction through the inhi- bition of the phosphorylation/activation of the EGF receptor

Pkg Ii Inhibits Pdgf-Bb Triggered Biological Activities By Phosphorylating Pdgfr In Gastric Cancer Cells

Type II Cgmp-Dependent Protein Kinase Inhibits EGF-induced MAPK/JNK Signal Transduction in Breast Cancer Cells

Pharmacological inhibition of Protein kinase D2/Aurora kinase A signalling axis suppresses G2/M cell cycle progression and proliferation of epithelial ovarian cancer cells

Type II Cyclic Guanosine Monophosphate-Dependent ProteinKinase Inhibits Vegf-A/Vegfr-2 Pathway Activation in GastricCancer Cells

Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.

PKG II Reverses HGF-triggered Cellular Activities by Phosphorylating Serine 985 of C-Met in Gastric Cancer Cells

Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.

TPX2 Gene Silencing Inhibits Cell Proliferation and Promotes Apoptosis Through Negative Regulation of AKT Signaling Pathway in Ovarian Cancer.

Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer